Neurorehabilitation Devices Market Report Study, Competitive Strategies and Forecast

Market Overview

The Neurorehabilitation Devices Market overview exhibiting a compound annual growth rate (CAGR) of 7.90% during the forecast period (2023 - 2032). Neurological rehabilitation is a treatment program overseen by a team of specialists for patients suffering from sickness, injury, or malfunction of the neurological system. Neurorehabilitation devices are used in the field of physiotherapy to aid in the learning of motor abilities. Neurorobotic systems, non-invasive brain stimulators, brain-computer interfaces, and wearable devices are all examples of neurorehabilitation equipment. With the use of these technologies, rehabilitation products have advanced and improved in terms of intensity and quality. It has ensured that neurorehabilitation equipment provides the best and most important results in neurological illnesses.

Market Segmentation

Based on the Type, the global Neurorehabilitation Devices Market outlook has been segmented into Neuro-Robotic Devices, Wearable Devices, Non-Invasive Stimulators, Brain-Computer, and Interface (BCIs).

Based on the Application, the global Neurorehabilitation Devices Market report has been segmented into Brain stroke, Parkinson's Disease, Multiple sclerosis, Spinal cord injury, Cerebral palsy, Schizophrenia, etc.

Based on the End-User, the global Neurorehabilitation Devices Market has been segmented into Hospitals/Clinics and Cognitive Care Centers.

Based on the Region, the global Neurorehabilitation Devices Market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Regional Classification 

North America dominates the worldwide market with the United States and Canada. The regional market has grown as the occurrences of Alzheimer's and Parkinson's disease has increased, leading to an increase in government financing through particular Senate of Canada programs. Europe consists of the UK, Germany, Italy, France, Belgium, Russia, Poland, and the rest of Europe. The Asia-Pacific includes India, Australia, New Zealand, China, South Korea, Japan, Thailand, Indonesia, and Vietnam, as well as the rest of the continent. The market for neurorehabilitation equipment is predicted to expand gradually. The architecture of medicine is changing, and it is expected that healthcare infrastructure and neurological devices will develop during the forecast period. According to statistics, market growth in areas where the majority of the population is over 60 years old ranges from 8.1 percent to 8.5 percent every year.

Competitive Landscape

The Neurorehabilitation Devices Market research players in the market are :

Abbott Laboratories,

Ekso Bionics Holdings Inc,

Helius Medical Technologies,

Hocoma AG,

Medtronic Inc,

Others

Following the pandemic, a developing culture of entrepreneurs, and neuroscientists, the Neurorehabilitation Devices Market is now open to a variety of people who wish to make money. Those who have invested in the Neurorehabilitation Devices Market have contributed to the advancement of this culture and market trends. In reality, patients are now consulting remotely for each of their application parts. As a result, it has provided a landscape for the neurorehabilitation device industry, as well as the possibility to interact with diverse persons to move the market forward. Parkinson's disease and stroke are the diseases with the highest CAGR in terms of application category in the coming years.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Small Molecule API Market Report by Major Manufacturers and Competitive landscape

Market Insights:

Market Research Future (MRFR)’s latest study asserts that the global small molecule API market is set to expand at a CAGR of 7.0% during the forecast period 2023 to 2030. The global small molecule API market share is set to reach a healthy growth by 2030. The increased investments in the research & findings coupled with government support are likely to propel the market growth in the forthcoming years.

The pharmaceutical industry is presently making massive profits and is equipped with developed infrastructure. The pharmaceutical industry is anticipated to expand in the foreseeable future. This, in turn, is expected to drive the growth of the small molecule API market. Additionally, the increase in the prevalence of diseases coupled with the discovery of new viruses and diseases is prognosticated to affect the small molecule API market proliferation positively.

Some of the factors responsible for favoring the expansion of the small molecule API market report include growing demand for small molecule drugs, rising access to the medication in developing and underdeveloped countries, entry of big CMOs into the market, etc. Furthermore, rising burden of cardiovascular diseases and cancer is forecasted to intensify the competition among the players of the small molecule API market. According to the American Cancer Society, 1,735,350 new cancer cases and 609,640 cancer deaths are estimated in the U.S. alone.

Market Segmentation:

By type, the small molecule API market trends has been segmented into synthetic/chemical API, and biological API. Synthetic/chemical API segment currently holds 81.4% share of the market. It is likely to retain its pole position over the forecast period.

By application, the global small molecule API market overview is segmented into cardiovascular, oncology, diabetes, immunological disorders, and others. The cardiovascular segment held the maximum share of the market in 2015. It is anticipated to show positive growth across the review period.

By manufacturing method, the small molecule API market has been segmented into in-house and contract.

Competitive Dashboard:

Small Molecule API Market players profiled in the report are Albemarle Corporation, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline Plc, Lonza, Merck Sharp & Dohme Corp., Allergan Plc, Aurobindo Pharma, Cambrex Corporation, Mylan N.V., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Novartis AG, Pfizer Inc., and Siegfried AG.

Regional Analysis:

By region, the global small molecule API market insights has been segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. North America is the largest market for small molecule API. It is expected to retain a significant market share through the assessment period. The factors favoring the expansion of the regional market include developed healthcare sector, availability of funds, increasing clinical trials, rising burden of cancer, etc.

Europe is the second largest small molecule API market. It is estimated to exhibit healthy growth over the next few years. The growth is attributable to the initiatives undertaken by the governments to support the expansion oh pharmaceutical industry. Furthermore, the availability of funds coupled with the adoption of next-gen healthcare technology is anticipated to aid market proliferation in the region.

Asia Pacific is projected to thrive at the highest CAGR during the review period. The Asian countries have an abundance of raw materials required for drug manufacturing. Additionally, low labor cost and regulatory relaxations have aided profit maximization for the regional market players. Asia Pacific is one of the significant exporters of small molecule drug, and the trend is projected to continue over the next few years.

The Middle East & Africa is set to exhibit steady growth. The African regions lack proper healthcare facilities and resonate strong growth opportunities. However, the Middle Eastern countries such as Qatar and Kuwait are expected to witness considerable growth due to the developed healthcare sector and increasing awareness.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

 

Smart Inhalers Market Report Trends, Recent Developments and Technology

Smart Inhalers Market – Overview

The use of smart technology has established a smart presence in the healthcare domain. This has led to an increased number of smart devices. Market focused reports linked with the healthcare industry among others recently have been made available by Market Research Future which issues reports on this industry. The smart inhalers market share is projected to expand with a 23.50% CAGR approximately while earning revenues worth USD 2.00 billion by the end of the forecast period 2032.

The need to monitor medicine dosage and schedule the medicine intake for smart inhalers market report has grown considerably. Due to the prevalence of ailments like asthma, the market has grown considerably over the past few years. As asthma patients are required to monitor their drug intake diligently, the smart inhalers provide a great degree of convenience in that regard. The development of the market is also powered by the incorporation of cutting-edge technologies in these products.

Detailed Regional Analysis

The smart inhalers market insights comprises regions such as North America, Middle East, Europe, Africa, APAC and rest of the world.  Globally, the North American region is the major market for smart inhalers which is predicted to touch $888.4 million in revenues approximately by 2023. The European region was the second biggest market in 2016 which is worth $57.4 million. Additionally, the Asia Pacific market is anticipated to be the most rapidly growing market and is likely to develop at a CAGR of 55.3 percent during the forecast period from 2016 to 2022. The smart inhalers market in the rest of world is anticipated to surge after 2019.

Global Competitive Analysis

The impetus for the market’s growth has altered the competitive background of the market. By ensuring supply and demand are in balance the competitors can unlock new opportunities for growth. The key players and trends have created a positive tone for development. The important trends and players have established a positive tone for development. The opportunities for growth and innovation have increased at a rapid pace transforming the landscape of the market. Engaging and converting prospective opportunities is modifying the growth pace of the market considerably. The competitors in the market have been spurred to devise strategic road-maps that capitalize on the positive market cues.

Smart inhalers market players are AstraZeneca, Gecko Health Innovations Inc., Cohero Health, Adherium, GlaxoSmithKline, Inspiro Medical, and Propeller Health.        

Industry Segments 

The smart inhalers market overview has been segmented on the basis of application, type, end user, and region. On the basis of type, the segment involves metered dose inhaler and dry powder inhaler. The dry powder inhalers control the principal share of the market. The application basis of segmentation of the market consists of asthma, COPD, and others. The end user segmentation of the market is segmented into respiratory care center, hospitals & clinics, and others. On the basis of regions, the market includes North America, APAC, Europe and rest of the world.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Meningococcal Vaccines Market Share : A Technology Analysis of the Key Products & Applications

Market Forecast

Meningococcal Vaccines Market share is projected to be worth USD 6.80 billion by 2032, registering a CAGR of 7.3% during the forecast period 2023 – 2032.

Market Synopsis

Meningococcal meningitis is a bacterial infection caused by Neisseria meningitides. Disease incidence is high in West and Central Africa, where historically, serogroup A has been the most important cause of disease. More recently, meningitis outbreaks have gradually been associated with serogroup C, and to a lesser extent, serogroup W.

The meningococcal vaccines market is complex and diverse, with regional variations in serogroup distribution with substantial use outside routine immunization. The vaccine has approximately 29 marketed products targeting various combinations of the six serogroups (A, B, C, W, X, Y).

Meningococcal Vaccines Market Segmentation

By treatment, the market is segmented into Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine.

Meningococcal A conjugate vaccine is significantly used in mass campaigns across affected regions like Africa. Since 2010, the vaccine has significantly decreased meningococcal disease incidence in the region. However, the demand for meningococcal A conjugate in the country remains uncertain given that national immunization program adoptions are based on the timing of Gavi funding decisions, the country’s readiness, and competing for vaccine introduction priorities.

In the polysaccharide segment, products such as MenACWY vaccines are in high demand. MenACWY vaccine is the most desirable combination, given its broader serotype coverage. MenACWY specifically has nine products that are available across polysaccharide and conjugate product segments, but conjugate products are suggested for use in routine immunization activities.

Moreover, the demand and supply of Subcap MenB vaccines is restricted to HICs and influenced by their acceptance into NIPs. Improved uptake of MenB vaccines is expected in the coming years but will likely be moderate and limited to high-income markets given the high price and competing interest of introducing MenACWY conjugate.

By end-user, the market is segmented into Hospital & Clinical, Research Laboratories, and Academic Institutes

Hospitals and clinics control the global meningococcal vaccines market insights. The high growth of hospitals and clinics segment is attributed to the increasing application of vaccines in these healthcare facilities in conjunction with the growing prevalence and incidence of the meningococcal disease.

Moreover, research laboratories and academic institutes take up the second-largest share due to the boost in research and development in the market.

By region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

In the global market, China is expected to have the largest market share, which accounts for approximately 35% of the global demand. This is primarily due to polysaccharide products, which currently comprise 84% of China’s demand. Chinese suppliers presently focus only on meeting the demand of the domestic market, but some of the manufacturers have indicated interest in the global market as well. The dynamic product pipeline with several multivalent conjugate products in development may trigger changes in the future supply mix of the Chinese market. Moreover, in China, non-routine use (excluding campaigns) accounts for an estimated 9 million doses in 2019, which may help to sustain the huge market share in the forecast period.

UNICEF foresees all 26 African countries in the meningitis belt, which have completed mass campaigns in 2016. In 2015, seven countries in the region were introduced with meningococcal A conjugate vaccine through their mass campaigns and targeted a population of 233 million. Further, during 2016-2018, UNICEF introduced meningococcal A conjugate vaccine in 26 countries. Ghana was the first country to be introduced with the vaccine into its RI schedule in 2016. Also, four other countries including Mali, Niger, Nigeria, and Sudan introduced the vaccine into RI programs in 2016.

Competitive landscape

The meningococcal vaccines market players are below.

• Baxter international
• Pfizer Inc.
• Sanofi S.A.
• Novartis Pharmaceuticals Inc.
• JN-International Medical Corporation
• Serum Institute of India Ltd.
• GlaxoSmithKline
• BIO-MED
• OthersTop of Form

Market Influencer

Without an increase in production, the existing supply of conjugate MenACWY will be inadequate to meet the demand generated by the rising incidence of serogroups C and W, and the low availability of polysaccharide vaccines. Further, several multivalent, conjugate vaccines by Chinese and Indian manufacturers are in the pipeline, and, if prequalified they will be registered for use in many geographies. Moreover, if they are made available at acceptable prices it could increase global demand in Meningococcal Vaccines Market Outlook.

Bottom of Form

 Bottom of Form

Bottom of Form

Bottom of Form

Bottom of Form

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Enteral Feeding Devices Market Share, Leading Players and Demand Forecast Report 2032

Market Overview

The global Enteral Feeding Devices Market share is predicted to meet the market value of USD 6.01 Billion by 2032 at a 5.10% CAGR for the forecast period of 2023 to 2032, according to the latest research report from Market Research Future (MRFR). The global enteral feeding devices market is profiled in detail in the report, which provides a comprehensive overview of the market’s leading drivers and restraints as well as the leading players operating in the market.

Enteral feeding devices are used to feed people who, permanently or temporarily, have lost the ability to feed themselves due to the disease or disorder. Enteral feeding devices are used to directly deliver nutrients into some part of the small intestine or stomach, so that at-risk patients can be fed under complete supervision. Enteral feeding devices also allow doctors to monitor and manage the temporary nutrition of specific individuals in order to make sure they are being fed as much and what they should be fed, considering specific diseases and disorders. The growing geriatric population around the world is likely to be a major driver for the global enteral feeding devices market over the forecast period, as the geriatric population is likely to be a major consumer of technologies that allow them to be fed without the hassle of physically feeding themselves. The growing number of geriatric individuals suffering from neurodegenerative diseases is also likely to be a major driver for the global Enteral Feeding Devices Market.

Releted Reports- 

https://kma.tribe.so/post/enteral-feeding-devices-market-by-business-top-key-players-growth-trend-to---656ed120e8d5e0cbf019b76d

https://buzz.talknewyorkcity.com/post/enteral-feeding-devices-market-size-insights-application-growth-drivers-656ed12282c08eb409897b9d

https://spider-web.mn.co/posts/46538090

https://roggle-delivery.tribe.so/post/enteral-feeding-devices-market-insights-overview-industry-analysis-and-fore--656ed125e5ac2f09de988555

https://healthcaresubmission.blogspot.com/2023/12/enteral-feeding-devices-market-share.html

https://www.click4r.com/posts/g/13314590/

https://followme.tribe.so/post/animal-genetics-market-by-business-top-key-players-growth-trend-to-2032-656ed20a4a5dd7b201556f76

https://yournetwork.tribe.so/post/animal-genetics-market-size-insights-application-growth-drivers-656ed20bbe7fe3f291fbcc57

https://tudomuaban.com/dang-tin-mien-phi.html

https://thankyou.tribe.so/post/animal-genetics-market-insights-overview-industry-analysis-and-forecasts-re--656ed22188381727b028e17e

https://healthcareanna.wordpress.com/2023/12/05/animal-genetics-market-share-leading-players-and-demand-forecast-report-2032/

https://www.social-vape.com/read-blog/92772

Segmentation:

The global enteral feeding devices market outlook has been segmented on the basis of product, age group, indication, end user, and region. 

·       By product, the market has been segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further categorized into enterostomy feeding tubes, nasoenteric feeding tubes, and oroenteric feeding tubes. The enterostomy feeding tubes segment is additionally divided into gastrostomy tubes, jejunostomy tubes, and gastrojejunostomy tubes. The nasoenteric feeding tubes segment is further classified into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The enteral feeding pumps segment is expected to dominate the market throughout the forecast period due to low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing adoption of pumps in hospitals and home care settings.

·       On the basis of age group, the market has been divided into adults and pediatrics. 

·       By indication, the market has been classified into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further categorized into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others. 

·       Based on end user, the market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs). 

Major players in the global enteral feeding devices market  are likely to focus on developing products that fit regulatory standards and enable steady growth for the company in the market. The growing scope for the medical devices sector in Asia Pacific is likely to be a key factor for the global enteral feeding devices market over the forecast period. 

Competitive Analysis:

Leading Enteral Feeding Devices Market Players include:  

§  Medtronic plc,

§  Cook Medical,

§  B. Braun Melsungen AG,

§  Abbott Laboratories,

§  Boston Scientific Corporation,

§  Becton,

§  Dickinson and Company (BD),

§  Fresenius Kabi AG,

§  Danone Nutricia,

§  Nestlé,

§  CONMED Corporation,

§  Moog, Inc.,

§  Halyard Health, Inc., and

§  Vygon SA.

Regional Analysis:

The Americas dominates the global enteral feeding devices market, followed by Europe. Asia Pacific is also likely to grow at a high CAGR over the forecast period. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013               

Medical Device Cleaning Market Share, Size, Trends, Industry Analysis Report to 2032

Medical Device Cleaning Market- Overview

Cleaning medical devices is an essential element of every surgical procedure. Since most medical devices (such as shears, scalpels, retractors, endoscopes, and forceps) are reused in healthcare procedures. Prior to actually being used in subsequent surgical procedures, the medical gadget must be sterilized and cleaned thoroughly to avoid any contamination among patients and the healthcare personnel. Disinfectants and cleansers for cleaning and sanitizing medical devices are found in medical device cleaning. The global Medical Device Cleaning Market Share is predicted to increase at a CAGR of 6.9% from 2023 to 2032.

Due to increased pharmaceutical manufacturing during the pandemic wave, coupled with favorable government initiatives, and the implementation of partial subsidy schemes to slash production costs, pharmaceutical excipients are in high demand.

The global medical device cleaning market dynamics is expected to be driven by stringent rules for reusable medical equipment to aid in reducing the severity of hospital-acquired infections (HAIs), increasing focus on sterilization and disinfection in the healthcare sector, increasing government investments to improve healthcare infrastructure, and increasing healthcare expenditure by patients. UV sanitizing devices are becoming increasingly popular among medical device cleaners. The UV sanitizer effectively kills bacteria on medical instruments and in operating rooms, with minimal contact and increased efficiency as compared to the manual cleaning methods is also estimated to be a key growth segment of the medical device cleaning market share.

Segmental Analysis

The segmentation of the medical device cleaning market outlook is broadly categorized by process, by end users, and by application.

·        On the basis of process, the market segmentation is subdivided into disinfection, automatic cleaning, manual cleaning, and presoak/precleaning. According to various analyses, the segment that is anticipated to have the highest CAGR is automatic cleaning. The primary factor responsible for this upsurge is the increase in demand for smart products and appliances.

·        On the basis of end users, the market is segmented into hospitals, pediatric centers, clinics, diagnostic centers, and dental clinics.

Detailed Regional Analysis

The global medical device cleaning market regions are North America, Europe, and the Asia Pacific. In 2020, North America dominated the market, accounting for about 33.73 percent of worldwide revenue. The increased share acquired by the area is projected to be due to a consistent number of strategic initiatives adopted by leading market players to broaden their brand portfolio and infection control competencies.

By 2028, the Asia-Pacific medical device cleaning market is projected to be valued at USD 8.12 billion. From 2021 to 2028, it is expected to register a CAGR of 11.2%. The development of new technologies for cleansing medical equipment and the increased adoption of preventive measures to limit hospital-acquired infections are the primary factors driving market expansion in the Asia-Pacific (APAC) region. Furthermore, rising concerns about healthcare-associated illnesses spreading through the environment or individuals are a crucial driver driving the APAC market forward. Surgical site infection, for example, is the top infection among overall patients in Asian nations, impacting roughly two-thirds of operated patients, which is nine times higher than in industrialized countries, according to the WHO Patient Safety information page. Furthermore, the Covid-19 pandemic and the high prevalence of infectious diseases are propelling market expansion in this region.

Competitive Analysis

Companies are also pursuing partnerships, mergers, and acquisitions in order to expand their product portfolios, production capabilities and create competitive differences. For instance, a company, PurpleSun Inc., based in the United States, has recently created UV technology that reduced more than 96% of microbes in operating rooms (ORs) and on medical equipment, which is more efficient than manual cleaning methods that rely on chemicals to sanitize surfaces, providing only 38%

The global Medical Device Cleaning Market Players are

         ·         Steris plc,

         ·         GetingeAB,

         ·         Advanced Sterilization Products,

         ·         Biotrol,

         ·         Oro Clean Chemie AG,

         ·         Cantel Medical Corp,

         ·         Sklar Surgical Instruments.

Related reports-

Microsurgery Market Research Report - Global Forecast till 2030

Breast Cancer Market Research Report - Forecast To 2030

Contract Research Organization (CRO) Market Research Report – Forecast till 2030

 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

 

Pacemaker Market Share accelerating a CAGR during the forecast period

Market summery -

Global Pacemaker Market Share is expected grow a CAGR of 3.60% over the forecast period of 2023-2032, as per the latest study report by Market Research Future (MRFR).

Pacemakers regularize heart rhythm by sending electric pulses to the heart and help in restoring cardiac activity. The surge in the prevalence of cardiac diseases has generated high demand for pacemakers which is driving the growth of the global pacemaker market. Atrial fibrillation, in particular, has witnessed a higher incidence rate in recent years which requires pacemakers for remediation. Increase in global geriatric population is also creating a conducive environment for the growth of the market. Atrial fibrillation and cardiac diseases are more prevalent in old patients. As per a 2018 study published in the Aging Medicine, there is 5 to 9% chance of occurrence of atrial fibrillation in patients between the age of 60-80 years and nearly 10% in patients aged over 80 years.

Technological advancements have resulted in the development of advanced pacemakers which are smaller in size and have longer battery life. Other factors aiding the growth of the market include an elevated level of awareness regarding cardiovascular diseases, improvement in reimbursement scenario, and high healthcare expenditure across the globe.

In recent years, various new pacemakers have received clearance from regulatory bodies which also has augmented the growth of the global pacemaker market. However, the approval and marketing if pacemakers are regulated by the US FDA which are stringent considering the degree of risk they pose to patients. Such stringent regulatory requirements might impede the growth of the market. High costs of pacemakers, risks involved in implantation procedures and risks of malfunctioning are other possible bottlenecks.

Segmentation

The global pacemaker market outlook has been segmented based on product type, application, implant approach, and end-user.

By product type, the global pacemaker market has been segmented into implantable and external. The implantable segment has been further segmented into single chamber, dual chamber, and biventricular.

By application, the global pacemaker market has been segmented into bradycardia, heart failure, hypertrophic cardiomyopathy, syncope, and others. The bradycardia segment has been further segmented into sinus node dysfunction and AV block.

By implant approach, the global pacemaker market has been segmented into endocardial approach and epicardial approach.

By end-user, the global pacemaker market has been segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others.

Competitive Landscape

Global pacemaker market players are below.

ZOLL Medical Corporation, MEDICO S.p.A, Cordis, Inc., St. Jude Medical Inc., Biotronik GmbH & Co. KG, Boston Scientific Corporation, General Electric Company, Pacetronix, Medtronic Plc, Sorin Group, Edwards Lifesciences, Cook, and Vitatron are the key players in the global pacemaker market.

Regional Analysis

By region, the global pacemaker market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

The Americas account for the largest share of the global pacemaker market. Presence of a robust healthcare sector and technological advancements accelerate the growth of the market. The FDA has also been approving various novel pacemakers in the region. Moreover, the presence of various medical device manufacturers and surging cases of cardiovascular disorders support market growth in the Americas.

Europe follows the Americas closely and ranks second in the global pacemaker market. Growing government support in the form of R&D grants and the growing presence of key players in the region drive the market in Europe. The growing incidence rate of cardiovascular diseases and high healthcare expenditure are other factors substantiating the growth of the market.

APAC pacemaker market is driven by the growing prevalence of atrial fibrillation in the region. In addition, the region has emerged as a medical tourism hub which is likely to propel the growth of the market. Increasing healthcare expenditure and the presence of a large pool of cardiac patients also will have a positive impact on market growth.

The MEA market is likely to exhibit sluggish growth due to lack of healthcare infrastructure, lack of technical knowledge and less awareness regarding cardiac medical conditions.

Abut US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America